Order Article Reprints

Pérez GV, Rosales M, Ramón AC, Rodríguez-Ulloa A, Besada V, González LJ, Aguilar D, Vázquez-Blomquist D, Falcón V, Caballero E, et al. CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell Model. Biomedicines. 2023; 11(1):43. https://doi.org/10.3390/biomedicines11010043

Pérez, George V., Mauro Rosales, Ailyn C. Ramón, Arielis Rodríguez-Ulloa, Vladimir Besada, Luis J. González, Daylen Aguilar, Dania Vázquez-Blomquist, Viviana Falcón, Evelin Caballero, and et al. 2023. "CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell Model" Biomedicines 11, no. 1: 43. https://doi.org/10.3390/biomedicines11010043

Pérez, G. V., Rosales, M., Ramón, A. C., Rodríguez-Ulloa, A., Besada, V., González, L. J., Aguilar, D., Vázquez-Blomquist, D., Falcón, V., Caballero, E., Carvalho, P. C., Caldeira, R. S., Yang, K., Perera, Y., & Perea, S. E. (2023). CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell Model. Biomedicines, 11(1), 43. https://doi.org/10.3390/biomedicines11010043